Back to: Facilitating Generic Drug Product Development through Product-Specific Guidances
🔔 Note: Stop playback at 1:37:47 to complete this lesson.
Presenter
Leah W. Falade, PhD
Senior Pharmacologist
Office of Product Quality Assessment II (OPQA II)
Office of Pharmaceutical Quality (OPQ)
Center for Drug Evaluation and Research (CDER)
US Food and Drug Administration (FDA)